SCHEMBL3857797

SCHEMBL3857797

CCN1CCC(O)(c2ccc(F)c(OC(F)F)c2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR5 P35346 1/20 0.41
DRD2 P14416 10/20 0.37
DRD3 P35462 4/20 0.37
HTR1A P08908 2/20 0.37
DRD1 P21728 2/20 0.37
DRD5 P21918 2/20 0.37
SLC6A2 P23975 2/20 0.37
HTR2A P28223 2/20 0.37
SLC6A4 P31645 2/20 0.37
HTR7 P34969 2/20 0.37
HRH1 P35367 2/20 0.37
HTR2B P41595 2/20 0.37
PDE4A P27815 2/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
SIGMAR1 Q99720 3/20 0.37
LMNA P02545 1/20 0.37
OPRL1 P41146 1/20 0.37
CCR3 P51677 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3853201 0.90 SSTR5 (0.44) SSTR5DRD2DRD3HTR1ADRD1
SCHEMBL3849548 0.86 OPRM1 (0.43) SSTR5DRD2DRD3HTR1ADRD1
SCHEMBL3849571 0.83 PDE4A (0.41) SSTR5SLC6A2SLC6A4PDE4APDE4B
SCHEMBL3851829 0.82 KCNN4 (0.44) SSTR5DRD2DRD3HTR1ADRD1
SCHEMBL3859481 0.81 DRD2 (0.48) SSTR5DRD2DRD3HTR1ADRD1
SCHEMBL3857772 0.78 OPRL1 (0.48) SSTR5DRD2DRD3HTR1ADRD1
SCHEMBL3850813 0.77 OPRM1 (0.46) SSTR5DRD2DRD3HTR1ADRD1
SCHEMBL3851762 0.76 SLC6A1 (0.39) DRD2OPRL1
SCHEMBL3857799 0.75 OPRL1 (0.55) DRD2DRD3HTR1ADRD1DRD5
SCHEMBL3853387 0.75 OPRL1 (0.51) DRD2DRD3HTR1ADRD1DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101076517-A Novel substituted piperidines as modulators of dopamine neurotransmission CARLSSON A RESEARCH AB (SE) 2007-11-21 CN claimed
CN-101076517-B Substituted piperidines as modulators of dopamine neurotransmission NSAB AF NEUROSEARCH SWEDEN AB 2010-12-15 CN disclosed
US-7579474-B2 Substituted piperidines as modulators of dopamine neurotransmission NSAB, FILIAL AF NEUROSEARCH AB, SVERIGE (DK) 2009-08-25 US disclosed
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2007-11-22 US disclosed
CN-101076517-A Novel substituted piperidines as modulators of dopamine neurotransmission CARLSSON A RESEARCH AB (SE) 2007-11-21 CN disclosed
EP-1765779-A1 NEW SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2007-03-28 EP disclosed
WO-2005121092-A1 NEW SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION DRD2, PRLHR, DRD3 SSTR5 417/4885DRD2 1/4885DRD3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.